Core Viewpoint - Moderna has signed a Memorandum of Understanding with the Mexican Government and local pharmaceutical companies to enhance Mexico's health sovereignty and establish a local mRNA manufacturing ecosystem [1] Group 1: Strategic Agreement - The agreement is a five-year strategic partnership aimed at strengthening health security in Mexico [1] - It includes the supply of Moderna's respiratory vaccine portfolio to Mexico [1] - Technology transfer will be provided to Laboratorios Liomont for the domestic manufacturing of Moderna's COVID-19 vaccine, mRNA-1273 [1] Group 2: Health Sovereignty and Manufacturing Resilience - The initiative supports "Plan Mexico," which focuses on building a local mRNA ecosystem [1] - The collaboration aims to create a reliable in-country supply of respiratory vaccines [1] - Laboratorios Liomont is noted for its state-of-the-art manufacturing facilities, which will be utilized for this purpose [1]